Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Translating Systems Medicine Into Clinical Practice: Examples From Pulmonary Medicine With Genetic Disorders, Infections, Inflammations, Cancer Genesis, and Treatment Implication of Molecular Alterations in Non-small-cell Lung Cancers and Personalized Medicine.
Pinsolle J, McLeer-Florin A, Giaj Levra M, de Fraipont F, Emprou C, Gobbini E, Toffart AC. Pinsolle J, et al. Among authors: emprou c. Front Med (Lausanne). 2019 Oct 29;6:233. doi: 10.3389/fmed.2019.00233. eCollection 2019. Front Med (Lausanne). 2019. PMID: 31737634 Free PMC article. Review.
Survival of clinical stage III NSCLC according to therapeutic strategy: Relevance of the tumor board decision in the era of immunotherapy.
Benet J, Toffart AC, Brichon PY, Chollier T, Ruckly S, Villa J, Emprou C, Pierret T, Dumas I, Ferretti G, Moro-Sibilot D, Levra MG. Benet J, et al. Among authors: emprou c. Cancer Treat Res Commun. 2022;30:100508. doi: 10.1016/j.ctarc.2021.100508. Epub 2022 Jan 4. Cancer Treat Res Commun. 2022. PMID: 35033834 Free article.
SNAI2 and TWIST1 in lymph node progression in early stages of NSCLC patients.
Emprou C, Le Van Quyen P, Jégu J, Prim N, Weingertner N, Guérin E, Pencreach E, Legrain M, Voegeli AC, Leduc C, Mennecier B, Falcoz PE, Olland A, Santelmo N, Quoix E, Massard G, Guenot D, Chenard MP, Beau-Faller M. Emprou C, et al. Cancer Med. 2018 Jul;7(7):3278-3291. doi: 10.1002/cam4.1545. Epub 2018 May 29. Cancer Med. 2018. PMID: 29845746 Free PMC article.
Treatment of antibody-mediated rejection with double-filtration plasmapheresis, low dose IVIg plus rituximab after kidney transplantation.
Naciri Bennani H, Daligault M, Noble J, Bardy B, Motte L, Giovannini D, Emprou C, Fiard G, Imerzoukene F, Bourdin A, Masson D, Janbon B, Malvezzi P, Rostaing L, Jouve T. Naciri Bennani H, et al. Among authors: emprou c. J Clin Apher. 2021 Aug;36(4):584-594. doi: 10.1002/jca.21897. Epub 2021 Mar 30. J Clin Apher. 2021. PMID: 33783868